Cargando…

Leveraging machine learning techniques for predicting pancreatic neuroendocrine tumor grades using biochemical and tumor markers

BACKGROUND: The incidence of pancreatic neuroendocrine tumors (PNETs) is now increasing rapidly. The tumor grade of PNETs significantly affects the treatment strategy and prognosis. However, there is still no effective way to non-invasively classify PNET grades. Machine learning (ML) algorithms have...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Rui-Quan, Ji, Hong-Chen, Liu, Qu, Zhu, Chun-Yu, Liu, Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6658377/
https://www.ncbi.nlm.nih.gov/pubmed/31367620
http://dx.doi.org/10.12998/wjcc.v7.i13.1611
_version_ 1783438953167192064
author Zhou, Rui-Quan
Ji, Hong-Chen
Liu, Qu
Zhu, Chun-Yu
Liu, Rong
author_facet Zhou, Rui-Quan
Ji, Hong-Chen
Liu, Qu
Zhu, Chun-Yu
Liu, Rong
author_sort Zhou, Rui-Quan
collection PubMed
description BACKGROUND: The incidence of pancreatic neuroendocrine tumors (PNETs) is now increasing rapidly. The tumor grade of PNETs significantly affects the treatment strategy and prognosis. However, there is still no effective way to non-invasively classify PNET grades. Machine learning (ML) algorithms have shown potential in improving the prediction accuracy using comprehensive data. AIM: To provide a ML approach to predict PNET tumor grade using clinical data. METHODS: The clinical data of histologically confirmed PNET cases between 2012 and 2018 were collected. A method of minimum P for the Chi-square test was used to divide the continuous variables into binary variables. The continuous variables were transformed into binary variables according to the cutoff value, while the P value was minimum. Four classical supervised ML models, including logistic regression, support vector machine (SVM), linear discriminant analysis (LDA) and multi-layer perceptron (MLP) were trained by clinical data, and the models were labeled with the pathological tumor grade of each PNET patient. The performance of each model, including the weight of the different parameters, were evaluated. RESULTS: In total, 91 PNET cases were included in this study, in which 32 were G1, 48 were G2 and 11 were G3. The results showed that there were significant differences among the clinical parameters of patients with different grades. Patients with higher grades tended to have higher values of total bilirubin, alpha fetoprotein, carcinoembryonic antigen, carbohydrate antigen 19-9 and carbohydrate antigen 72-4. Among the models we used, LDA performed best in predicting the PNET tumor grade. Meanwhile, MLP had the highest recall rate for G3 cases. All of the models stabilized when the sample size was over 70 percent of the total, except for SVM. Different parameters varied in affecting the outcomes of the models. Overall, alanine transaminase, total bilirubin, carcinoembryonic antigen, carbohydrate antigen 19-9 and carbohydrate antigen 72-4 affected the outcome greater than other parameters. CONCLUSION: ML could be a simple and effective method in non-invasively predicting PNET grades by using the routine data obtained from the results of biochemical and tumor markers.
format Online
Article
Text
id pubmed-6658377
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-66583772019-07-31 Leveraging machine learning techniques for predicting pancreatic neuroendocrine tumor grades using biochemical and tumor markers Zhou, Rui-Quan Ji, Hong-Chen Liu, Qu Zhu, Chun-Yu Liu, Rong World J Clin Cases Retrospective Study BACKGROUND: The incidence of pancreatic neuroendocrine tumors (PNETs) is now increasing rapidly. The tumor grade of PNETs significantly affects the treatment strategy and prognosis. However, there is still no effective way to non-invasively classify PNET grades. Machine learning (ML) algorithms have shown potential in improving the prediction accuracy using comprehensive data. AIM: To provide a ML approach to predict PNET tumor grade using clinical data. METHODS: The clinical data of histologically confirmed PNET cases between 2012 and 2018 were collected. A method of minimum P for the Chi-square test was used to divide the continuous variables into binary variables. The continuous variables were transformed into binary variables according to the cutoff value, while the P value was minimum. Four classical supervised ML models, including logistic regression, support vector machine (SVM), linear discriminant analysis (LDA) and multi-layer perceptron (MLP) were trained by clinical data, and the models were labeled with the pathological tumor grade of each PNET patient. The performance of each model, including the weight of the different parameters, were evaluated. RESULTS: In total, 91 PNET cases were included in this study, in which 32 were G1, 48 were G2 and 11 were G3. The results showed that there were significant differences among the clinical parameters of patients with different grades. Patients with higher grades tended to have higher values of total bilirubin, alpha fetoprotein, carcinoembryonic antigen, carbohydrate antigen 19-9 and carbohydrate antigen 72-4. Among the models we used, LDA performed best in predicting the PNET tumor grade. Meanwhile, MLP had the highest recall rate for G3 cases. All of the models stabilized when the sample size was over 70 percent of the total, except for SVM. Different parameters varied in affecting the outcomes of the models. Overall, alanine transaminase, total bilirubin, carcinoembryonic antigen, carbohydrate antigen 19-9 and carbohydrate antigen 72-4 affected the outcome greater than other parameters. CONCLUSION: ML could be a simple and effective method in non-invasively predicting PNET grades by using the routine data obtained from the results of biochemical and tumor markers. Baishideng Publishing Group Inc 2019-07-06 2019-07-06 /pmc/articles/PMC6658377/ /pubmed/31367620 http://dx.doi.org/10.12998/wjcc.v7.i13.1611 Text en ©The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
spellingShingle Retrospective Study
Zhou, Rui-Quan
Ji, Hong-Chen
Liu, Qu
Zhu, Chun-Yu
Liu, Rong
Leveraging machine learning techniques for predicting pancreatic neuroendocrine tumor grades using biochemical and tumor markers
title Leveraging machine learning techniques for predicting pancreatic neuroendocrine tumor grades using biochemical and tumor markers
title_full Leveraging machine learning techniques for predicting pancreatic neuroendocrine tumor grades using biochemical and tumor markers
title_fullStr Leveraging machine learning techniques for predicting pancreatic neuroendocrine tumor grades using biochemical and tumor markers
title_full_unstemmed Leveraging machine learning techniques for predicting pancreatic neuroendocrine tumor grades using biochemical and tumor markers
title_short Leveraging machine learning techniques for predicting pancreatic neuroendocrine tumor grades using biochemical and tumor markers
title_sort leveraging machine learning techniques for predicting pancreatic neuroendocrine tumor grades using biochemical and tumor markers
topic Retrospective Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6658377/
https://www.ncbi.nlm.nih.gov/pubmed/31367620
http://dx.doi.org/10.12998/wjcc.v7.i13.1611
work_keys_str_mv AT zhouruiquan leveragingmachinelearningtechniquesforpredictingpancreaticneuroendocrinetumorgradesusingbiochemicalandtumormarkers
AT jihongchen leveragingmachinelearningtechniquesforpredictingpancreaticneuroendocrinetumorgradesusingbiochemicalandtumormarkers
AT liuqu leveragingmachinelearningtechniquesforpredictingpancreaticneuroendocrinetumorgradesusingbiochemicalandtumormarkers
AT zhuchunyu leveragingmachinelearningtechniquesforpredictingpancreaticneuroendocrinetumorgradesusingbiochemicalandtumormarkers
AT liurong leveragingmachinelearningtechniquesforpredictingpancreaticneuroendocrinetumorgradesusingbiochemicalandtumormarkers